Cellectar Biosciences, Inc. (CLRB): Price and Financial Metrics
CLRB Price/Volume Stats
| Current price | $1.56 | 52-week high | $4.45 |
| Prev. close | $1.61 | 52-week low | $1.55 |
| Day low | $1.55 | Volume | 744,100 |
| Day high | $1.69 | Avg. volume | 892,658 |
| 50-day MA | $2.05 | Dividend yield | N/A |
| 200-day MA | $2.75 | Market Cap | 64.38M |
CLRB Stock Price Chart Interactive Chart >
Cellectar Biosciences, Inc. (CLRB) Company Bio
Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is based in Madison, Wisconsin.
CLRB Price Returns
| 1-mo | -26.42% |
| 3-mo | -26.42% |
| 6-mo | -49.84% |
| 1-year | -29.09% |
| 3-year | -79.68% |
| 5-year | -90.00% |
| YTD | -43.68% |
| 2023 | 61.99% |
| 2022 | -74.25% |
| 2021 | -68.08% |
| 2020 | -7.56% |
| 2019 | 45.16% |
Loading social stream, please wait...